Paolo Marchetti

1.1k total citations
51 papers, 850 citations indexed

About

Paolo Marchetti is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Paolo Marchetti has authored 51 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Organic Chemistry, 22 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Paolo Marchetti's work include Synthesis and biological activity (6 papers), Asymmetric Synthesis and Catalysis (6 papers) and Synthetic Organic Chemistry Methods (6 papers). Paolo Marchetti is often cited by papers focused on Synthesis and biological activity (6 papers), Asymmetric Synthesis and Catalysis (6 papers) and Synthetic Organic Chemistry Methods (6 papers). Paolo Marchetti collaborates with scholars based in Italy, United States and Taiwan. Paolo Marchetti's co-authors include Vinicio Zanirato, Daniele Simoni, Riccardo Baruchello, Carmela De Risi, G. P. POLLINI, Simonetta Benetti, A. BARCO, Riccardo Rondanin, Ferruccio D’Angeli and Manuela Labbozzetta and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of the New York Academy of Sciences.

In The Last Decade

Paolo Marchetti

49 papers receiving 826 citations

Peers

Countries citing papers authored by Paolo Marchetti

Since Specialization

Citations

This map shows the geographic impact of Paolo Marchetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Marchetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Marchetti more than expected).

Fields of papers citing papers by Paolo Marchetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Marchetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Marchetti. The network helps show where Paolo Marchetti may publish in the future.

Co-authorship network of co-authors of Paolo Marchetti

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Marchetti. A scholar is included among the top collaborators of Paolo Marchetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Marchetti. Paolo Marchetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multi-Step Synthesis of Chimeric Nutlin–DCA Compounds Targeting Dual Pathways for Treatment of Cancer 2025 ·Molecules ·(unknown), (unknown), Paolo Marchetti, Vinicio Zanirato, Anna Fantinati, Claudio Trapella, Rebecca Voltan, (unknown)	1
2	Anticancer Activity and Molecular Mechanisms of an Ursodeoxycholic Acid Methyl Ester-Dihydroartemisinin Hybrid via a Triazole Linkage in Hepatocellular Carcinoma Cells 2023 ·Molecules ·Ya-Fen Hsu, Fan‐Lu Kung, (unknown), (unknown), Jih‐Hwa Guh, Paolo Marchetti, Elena Marchesi, Daniela Perrone, Maria Luisa Navacchia, Lih‐Ching Hsu	3
3	Characterization of Stable Pyrazole Derivatives of Curcumin with Improved Cytotoxicity on Osteosarcoma Cell Lines 2023 ·Life ·Giordana Feriotto, Riccardo Rondanin, Paolo Marchetti, Federico Tagliati, Simone Beninati, Claudio Tabolacci, (unknown), (unknown), Carlo Mischiati	5
4	Cytotoxicity of Isoxazole Curcumin Analogs on Chronic Myeloid Leukemia-Derived K562 Cell Lines Sensitive and Resistant to Imatinib 2023 ·International Journal of Molecular Sciences ·Giordana Feriotto, Paolo Marchetti, Riccardo Rondanin, Federico Tagliati, (unknown), Simone Beninati, Fabio Casciano, Claudio Tabolacci, Carlo Mischiati	7
5	Synthesis and NLRP3-Inflammasome Inhibitory Activity of the Naturally Occurring Velutone F and of Its Non-Natural Regioisomeric Chalconoids 2022 ·International Journal of Molecular Sciences ·(unknown), Mariasole Perrone, Sonia Missiroli, Paolo Pinton, Paolo Marchetti, (unknown), (unknown), (unknown), (unknown), Anna Fantinati, (unknown), Carlotta Giorgi, Claudio Trapella, Vinicio Zanirato	3
6	Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma Cells 2020 ·Frontiers in Pharmacology ·(unknown), (unknown), Jui‐Ling Hsu, (unknown), Elena Marchesi, Massimo L. Capobianco, Paolo Marchetti, Maria Luisa Navacchia, Jih‐Hwa Guh, Daniela Perrone, Lih‐Ching Hsu	30
7	The Fascinating Chemistry of α‐Haloamides 2020 ·ChemistryOpen ·Anna Fantinati, Vinicio Zanirato, Paolo Marchetti, Claudio Trapella	38
8	A novel hybrid drug between two potent anti-tubulin agents as a potential prolonged anticancer approach 2016 ·European Journal of Pharmaceutical Sciences ·Paolo Marchetti, Barbara Pavan, Daniele Simoni, Riccardo Baruchello, Riccardo Rondanin, Carlo Mischiati, Giordana Feriotto, Luca Ferraro, Lih‐Ching Hsu, Ray M. Lee, Alessandro Dalpiaz	8
9	Hemiasterlin derivative (R)(S)(S)-BF65 and Akt inhibitor MK-2206 synergistically inhibit SKOV3 ovarian cancer cell growth 2016 ·Biochemical Pharmacology ·(unknown), (unknown), Riccardo Baruchello, Riccardo Rondanin, Paolo Marchetti, Daniele Simoni, Ray M. Lee, Jih‐Hwa Guh, Lih‐Ching Hsu	7
10	Inhibition of activated STAT5 in Bcr/Abl expressing leukemia cells with new pimozide derivatives 2014 ·Bioorganic & Medicinal Chemistry Letters ·Riccardo Rondanin, Daniele Simoni, Romeo Romagnoli, Riccardo Baruchello, Paolo Marchetti, (unknown), (unknown), (unknown), Stefania Grimaudo, Rosaria Maria Pipitone, Maria Meli, Manlio Tolomeo	23
11	Development of hemiasterlin derivatives as potential anticancer agents that inhibit tubulin polymerization and synergize with a stilbene tubulin inhibitor 2011 ·Investigational New Drugs ·Lih‐Ching Hsu, David Durrant, (unknown), Nai‐Wen Chi, Riccardo Baruchello, Riccardo Rondanin, (unknown), Paolo Marchetti, Giuseppina Grisolia, Daniele Simoni, Ray M. Lee	10
12	Versatile synthesis of new cytotoxic agents structurally related to hemiasterlins 2010 ·Bioorganic & Medicinal Chemistry Letters ·Daniele Simoni, Ray M. Lee, David Durrant, Nai‐Wen Chi, Riccardo Baruchello, Riccardo Rondanin, (unknown), Paolo Marchetti	8
13	Lack of nucleophilic addition in the isoxazole and pyrazole diketone modified analogs of curcumin; implications for their antitumor and chemosensitizing activities 2009 ·Chemico-Biological Interactions ·Manuela Labbozzetta, Riccardo Baruchello, Paolo Marchetti, Maria Concetta Gueli, Paola Poma, Monica Notarbartolo, Daniele Simoni, Natale D’Alessandro	47
14	Design, synthesis and biological evaluation of novel stilbene-based antitumor agents 2008 ·Bioorganic & Medicinal Chemistry ·Daniele Simoni, Francesco Paolo Invidiata, (unknown), Paolo Marchetti, Riccardo Rondanin, Riccardo Baruchello, Giuseppina Grisolia, Ashutosh Tripathi, Glen E. Kellogg, David Durrant, Ray M. Lee	24
15	Antitumor effects of curcumin and structurally β-diketone modified analogs on multidrug resistant cancer cells 2007 ·Bioorganic & Medicinal Chemistry Letters ·Daniele Simoni, (unknown), Riccardo Rondanin, Riccardo Baruchello, Paolo Marchetti, Francesco Paolo Invidiata, Manuela Labbozzetta, Paola Poma, Valeria Carina, Monica Notarbartolo, (unknown), Natale D’Alessandro	73
16	Stilbene-based anticancer agents: Resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanism 2006 ·Bioorganic & Medicinal Chemistry Letters ·Daniele Simoni, Marinella Roberti, Francesco Paolo Invidiata, Enrico Aiello, Stefania Aiello, Paolo Marchetti, Riccardo Baruchello, (unknown), Antonietta Di Cristina, Stefania Grimaudo, Nicola Gebbia, Lucia Crosta, Francesco Dieli, Manlio Tolomeo	64
17	Single diastereomeric desaminotyrosylalanyl tetra‐ and heptapeptides with opioid antagonistic activity 1995 ·International journal of peptide & protein research ·Gianfranco Balboni, Severo Salvadori, Ferruccio D’Angeli, Paolo Marchetti, L.H. Lazarus, Sharon D. Bryant, Claudia L. Bianchi‬	1
18	STEREOSELECTIVE FORMATION OF GLYCOCONJUGATED LACTAMIDES FROM CHIRAL 2-BROMOPROPANAMIDES 1994 ·Gazzetta chimica italiana ·(unknown), Paolo Marchetti, (unknown), P. L. BARILI, Giorgio Catelani	0
19	Ether-amides and Glycoside-amides from 2-Bromoisobutyramides and Saccharides bearing a Free Primary, Secondary or Anomeric Alcoholic Group. 1992 ·Gazzetta chimica italiana ·Giorgio Catelani, (unknown), Ferruccio D’Angeli, Giorgio Cavicchioni, Paolo Marchetti	0
20	BASE-PROMOTED CYCLOCOUPLING REACTION OF 2-BROMOPROPANAMIDES AND 2-BROMOACETAMIDES WITH DMF 1989 ·Gazzetta chimica italiana ·Ferruccio D’Angeli, Giorgio Cavicchioni, Giorgio Catelani, Paolo Marchetti, Flavio Maran	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact